Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
M&A
Pharma
AZ leans on cancer, rare disease muscle in solid Q2
In 2026’s second quarter, AstraZeneca generated revenue of nearly $15.4 million, growing 5% over the same period in 2025 at constant currencies.
Fraiser Kansteiner
Jul 27, 2026 10:21am
Generic tariffs, Samsung Bio, HK IPO—Fierce Pharma Asia
Jul 24, 2026 9:00am
Sanofi announces limited changes to its revamped executive team
Jul 21, 2026 1:35pm
Vertex to pay $10B for Crinetics in its largest-ever deal
Jul 7, 2026 8:08am
Kimball makes $103M bid to grow its CDMO footprint in EU, India
Jul 1, 2026 10:22am
After trial fail, Teravance is bought out by Zymeworks for $929M
Jun 29, 2026 11:30am
